-
EP4274541
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4274541
| EP4274541 - HYDROXY-SUBSTITUTED SPHINGOLIPIDS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 13.10.2023 Database last updated on 19.10.2024 | |
| Former | The international publication has been made Status updated on 15.07.2022 | ||
| Former | unknown Status updated on 10.01.2022 | Most recent event Tooltip | 08.03.2024 | Change: Validation states | published on 10.04.2024 [2024/15] | 08.03.2024 | Change - extension states | published on 10.04.2024 [2024/15] | Applicant(s) | For all designated states Evonik Operations GmbH Rellinghauser Straße 1-11 45128 Essen / DE | [2023/46] | Inventor(s) | 01 /
LU, Xin 45257 Essen / DE | 02 /
SCHILD, Jennifer 42653 Solingen / DE | 03 /
NATTLAND, Sandra 45359 Essen / DE | 04 /
BAETSEN, Marita Regina 47661 Issum / DE | 05 /
MACZKIEWITZ, Ursula 45219 Essen / DE | 06 /
WENK, Hans Henning 45470 Mülheim an der Ruhr / DE | 07 /
VAN LOGCHEM, Monica Desiree 4762 PA Zevenbergen / NL | 08 /
MAUS, Lisa 47228 Duisburg / DE | [2023/46] | Representative(s) | Evonik Patent Association c/o Evonik Industries AG IP Management Bau 1042A/PB 15 Paul-Baumann-Straße 1 45772 Marl / DE | [2023/46] | Application number, filing date | 22700002.3 | 05.01.2022 | [2023/46] | WO2022EP50107 | Priority number, date | EP20210150361 | 06.01.2021 Original published format: EP 21150361 | [2023/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022148758 | Date: | 14.07.2022 | Language: | EN | [2022/28] | Type: | A1 Application with search report | No.: | EP4274541 | Date: | 15.11.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.07.2022 takes the place of the publication of the European patent application. | [2023/46] | Search report(s) | International search report - published on: | EP | 14.07.2022 | Classification | IPC: | A61K8/36, A61K8/37, A61K8/63, A61K8/68, A61P17/00, A61P17/02, A61P17/16, A61Q19/00 | [2023/46] | CPC: |
A61K8/361 (EP);
C07C235/08 (KR,US);
A61K8/37 (EP);
A61K8/42 (US);
A61K8/498 (US);
A61K8/63 (EP);
A61K8/68 (EP,KR);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/16 (EP);
A61Q19/00 (EP);
A61Q19/08 (KR,US);
B01J31/0244 (US);
C07C231/02 (KR);
C07C233/18 (KR);
C07C235/74 (US);
C07D309/10 (US);
C07H1/00 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/46] | Title | German: | HYDROXY-SUBSTITUIERTE SPHINGOLIPIDE | [2023/46] | English: | HYDROXY-SUBSTITUTED SPHINGOLIPIDS | [2023/46] | French: | SPHINGOLIPIDES HYDROXY-SUBSTITUÉS | [2023/46] | Entry into regional phase | 25.07.2023 | National basic fee paid | 25.07.2023 | Designation fee(s) paid | 25.07.2023 | Examination fee paid | Examination procedure | 25.07.2023 | Examination requested [2023/46] | 25.07.2023 | Date on which the examining division has become responsible | 12.02.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 25.01.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDY]FR2855049 (OREAL [FR]); | [XY]DE102008002410 (EVONIK GOLDSCHMIDT GMBH [DE]); | [XY]DE102008002409 (EVONIK GOLDSCHMIDT GMBH [DE]); | [X]WO2015013634 (EBERTING CHERYL LEE [US]); | [XY]EP3546589 (EVONIK DEGUSSA GMBH [DE]) | by applicant | EP1180359 | FR2855049 | FR2874610 | DE102004027475 | DE20081001788 |